These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16490627)

  • 1. Effect of ramipril on left ventricular mass in normotensive hemodialysis patients.
    Yu WC; Lin YP; Lin IF; Chuang SY; Chen CH
    Am J Kidney Dis; 2006 Mar; 47(3):478-84. PubMed ID: 16490627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of ramipril and spironolactone on ventricular remodeling after acute myocardial infarction: randomized and double-blind study].
    Rodríguez JA; Godoy I; Castro P; Quintana JC; Chávez E; Yovanovich J; Corbalán R; Chávez A
    Rev Med Chil; 1997 Jun; 125(6):643-52. PubMed ID: 9515282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
    Suzuki H; Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H
    Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of ramipril on the glucose/insulin coefficient and the ventricular mass index in patients with light to moderate arterial hypertension].
    Germán Cardona-Muñoz E; Noriega-Arellano J; Hernández-Chávez A; López-Alvarado A; González-Ortiz M; Martínez-Abundis E; Delgado Hurtado JM; Ramos-Remus C; Gamez-Nava I; Ayub-Ayala M
    Arch Cardiol Mex; 2003; 73(1):24-30. PubMed ID: 12820491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Improvement in diastolic function in hypertensive patients with left ventricular hypertrophy with inhibitors of the angiotensin converting enzyme].
    Sagastagoitia JD; Morillas M; Martínez A; Lage E; Pallarés C; Ugartemendía C; Asín E; Barrios V; Julia J; Sánchez P; Calvo C; González J; Piña C; García-Barbal J; Arnau C
    Rev Clin Esp; 1998 Jan; 198(1):15-22. PubMed ID: 9580230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
    Aznaouridis KA; Vyssoulis GP; Karpanou EA; Marinakis AG; Barbetseas JD; Zervoudaki AI; Cokkinos DV; Stefanadis CI
    Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of angiotensin receptor blockade on systemic right ventricular function and size: a small, randomized, placebo-controlled study.
    Therrien J; Provost Y; Harrison J; Connelly M; Kaemmerer H; Webb GD
    Int J Cardiol; 2008 Sep; 129(2):187-92. PubMed ID: 18672299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Remission of left ventricular hypertrophy with ramipril independently of blood pressure changes: the HYCAR study (cardiac hypertrophy and ramipril)].
    Lièvre M; Guéret P; Gayet C; Roudaut R; Delair S; Boissel JP
    Arch Mal Coeur Vaiss; 1995 Feb; 88 Spec No 2():35-42. PubMed ID: 7646310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE inhibitors and persistent left ventricular hypertrophy after renal transplantation: a randomized clinical trial.
    Paoletti E; Cassottana P; Amidone M; Gherzi M; Rolla D; Cannella G
    Am J Kidney Dis; 2007 Jul; 50(1):133-42. PubMed ID: 17591533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of amlodipine or ramipril treatment on left ventricular mass and carotid intima-media thickness in nondiabetic hemodialysis patients.
    Yilmaz R; Altun B; Kahraman S; Ozer N; Akinci D; Turgan C
    Ren Fail; 2010; 32(8):903-12. PubMed ID: 20722555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of angiotensin-converting enzyme inhibition on mitral regurgitation severity, left ventricular size, and functional capacity.
    Harris KM; Aeppli DM; Carey CF
    Am Heart J; 2005 Nov; 150(5):1106. PubMed ID: 16291006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in cardiac muscle mass and function in hemodialysis patients during growth hormone treatment.
    Jensen PB; Ekelund B; Nielsen FT; Baumbach L; Pedersen FB; Oxhøj H
    Clin Nephrol; 2000 Jan; 53(1):25-32. PubMed ID: 10661479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Left ventricular hypertrophy in patients on hemodialysis: importance of anemia].
    Stojimirović B; Petrović D; Obrenović R
    Med Pregl; 2007; 60 Suppl 2():155-9. PubMed ID: 18928184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial.
    Lonn E; Shaikholeslami R; Yi Q; Bosch J; Sullivan B; Tanser P; Magi A; Yusuf S
    J Am Coll Cardiol; 2004 Jun; 43(12):2200-6. PubMed ID: 15193680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beneficial effects of Hartil on cardiovascular remodeling process in elderly and old patients with isolated systolic arterial hypertension].
    Kiphshidze N; Zubiashvili T; Chagunava K
    Georgian Med News; 2008 Jan; (154):7-13. PubMed ID: 18323584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regression of left ventricular hypertrophy in hypertensive patients].
    Bosa Ojeda F; García González M; Domínguez Rodríguez A; Barragán Acea A; Miralles Ibarra JM; Lacalzada Almeida J; de Armas Trujillo D
    Rev Esp Cardiol; 1997; 50 Suppl 4():74-6. PubMed ID: 9411592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin converting enzyme inhibition for cardiac hypertrophy in patients with end-stage renal disease: what is the evidence?
    Wang AY; Li PK; Lui SF; Sanderson JE
    Nephrology (Carlton); 2004 Aug; 9(4):190-7. PubMed ID: 15363049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular hypertrophy: a "factor of risk": mass is reversible, but is the risk?
    Frohlich ED
    J Am Coll Cardiol; 2004 Jun; 43(12):2216-8. PubMed ID: 15193682
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
    Ferrari R;
    Arch Intern Med; 2006 Mar; 166(6):659-66. PubMed ID: 16567606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.